In 2022, the World Health Organization (WHO) renamed monkeypox to Mpox to reduce stigma. Mpox is a viral disease that typically affects rodents but can also infect humans. Its symptoms include fever, rashes, and swollen lymph nodes. The virus spreads through close contact, contaminated objects, and respiratory droplets. Due to its rising global cases and potential severity, WHO declared Mpox a global health emergency. This declaration aims to enhance global response efforts, including vaccination and public health education, to curb the spread.
Understanding Symptoms and Transmission
Mpox starts with flu-like symptoms, followed by a rash that can spread across the body. It spreads through direct contact with infected individuals, respiratory droplets, and contaminated items like bedding. This transmission makes it crucial to take preventive measures seriously.
Global Impact and WHO’s Response
The growing number of Mpox cases globally has prompted WHO to declare it a global health emergency. This status is a call for international cooperation in monitoring, preventing, and managing the disease. The response includes vaccination campaigns in high-risk areas and public health initiatives to educate communities on preventing the spread.
Key Preventive Measures
To prevent Mpox, it’s essential to raise awareness, quickly identify and isolate cases, and promote vaccination where needed. WHO’s ongoing efforts focus on guiding countries in managing outbreaks and protecting public health.
As Mpox continues to spread, global awareness and cooperation are vital in combating the virus. WHO’s declaration underscores the seriousness of the situation and the need for immediate action to prevent a wider outbreak.
